Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Head and Neck Neoplasms 2Neoplasms 1Mouth Neoplasms 1

Interventions

Cisplatin 7Cetuximab 6Radiotherapy, Intensity-Modulated 4pembrolizumab 3durvalumab 3Radiotherapy 2Radiation 2Observation 2Drug Therapy 2Celecoxib 2Bupropion 2130-nm albumin-bound paclitaxel 2trametinib 1sodium thiosulfate 1gluconic acid 1ficlatuzumab 1Zinc 1Watchful Waiting 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1Tobacco Use Cessation Devices 1Tadalafil 1Sirolimus 1RRx-001 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Pilocarpine 1Photochemotherapy 1Periodontal Debridement 1Oral Hygiene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Mouth Neoplasms × Zinc × Clear all
NCT00210470 2020-12-11

A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer

Brooklyn ImmunoTherapeutics, LLC

Phase 2 Completed
27 enrolled 16 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡